Company Filing History:

4 out of 119

Ucb S.a.

Years Active: 2004-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8492416 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2013-07-23),

2. 8034958 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2011-10-11),

3. 7692028 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2010-04-06),

4. 7358276 - 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2008-04-15),

5. 6911461 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2005-06-28),

6. 6806287 - 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses (2004-10-19),

7. 6784197 - 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses (2004-08-31),

Title: The Innovative Contributions of Patrick Pasau

Introduction

Patrick Pasau is a distinguished inventor based in Chastre, Belgium, known for his innovative contributions in the field of pharmaceuticals. With a remarkable portfolio of seven patents, he has focused extensively on developing compounds that address critical medical issues, particularly in treating neurological disorders such as epilepsy.

Latest Patents

Among his latest patents, Patrick has made significant strides with his inventions related to 2-oxo-1-pyrrolidine derivatives. These compounds, defined by their unique formula I, showcase potential therapeutic applications as pharmaceuticals. The inventions specifically target the treatment of neurological disorders, highlighting Patrick's commitment to advancing medical science through his innovative work.

Career Highlights

Throughout his career, Patrick has worked with prominent companies in the pharmaceutical industry, including UCB S.A. and UCB Pharma S.A. His contributions have been instrumental in shaping the research and development processes within these organizations, showcasing his expertise and dedication to innovation in the pharmaceutical field.

Collaborations

Patrick has collaborated with esteemed colleagues such as Edmond Differding and Alain Matagne, further enriching his experience and expanding his network within the industry. These partnerships have likely facilitated the exchange of ideas and made significant impacts on his research endeavors.

Conclusion

Patrick Pasau's innovative spirit and extensive patent portfolio underscore his role as a key inventor in the pharmaceutical domain. His work, particularly with 2-oxo-1-pyrrolidine derivatives, not only contributes to advancing medical treatment options but also exemplifies the vital role of inventors in developing solutions to complex health challenges. As Patrick continues his work, the impact of his inventions is sure to resonate within the medical community for years to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.